{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T11:03:46Z","timestamp":1786273426574,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","surgjournal.com","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.surg.2024.07.061","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T11:46:26Z","timestamp":1727351186000},"page":"108806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Nonsteroidal anti-inflammatory drug (NSAID) prescribing after gastrojejunostomy: A preventable cause of morbidity"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5497-5634","authenticated-orcid":false,"given":"Abby","family":"Gross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Gentle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chase J.","family":"Wehrle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Nimylowycz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayf","family":"Said Al-deen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Aminian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toms","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2024.07.061_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s11695-014-1482-9","article-title":"Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass: incidence, risk factors and management","volume":"25","author":"Coblijn","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/j.surg.2024.07.061_bib2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.21037\/gs-20-763","article-title":"Risk factors for perforated marginal ulcers following pancreaticoduodenectomy and prospective analysis of marginal ulcer development","volume":"10","author":"Luu","year":"2021","journal-title":"Gland Surg"},{"key":"10.1016\/j.surg.2024.07.061_bib3","first-page":"3260","article-title":"Incidence and clinical features of endoscopic ulcers developing after gastrectomy","volume":"18","author":"Chung","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surg.2024.07.061_bib4","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1007\/s00464-012-2280-x","article-title":"Marginal ulcer after Roux-en-Y gastric bypass: what have we really learned?","volume":"26","author":"El-Hayek","year":"2012","journal-title":"Surg Endosc"},{"key":"10.1016\/j.surg.2024.07.061_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.surg.2020.02.012","article-title":"Symptomatic marginal ulcer after pancreatoduodenectomy","volume":"168","author":"Sulieman","year":"2020","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2024.07.061_bib6","first-page":"4336","article-title":"Marginal ulcers after Roux-en-Y gastric bypass: etiology, diagnosis, and management","volume":"12","author":"Salame","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.surg.2024.07.061_bib7","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1007\/s11695-021-05363-4","article-title":"Incidence and prognostic factors for the development of symptomatic and asymptomatic marginal ulcers after Roux-en-Y gastric bypass procedures","volume":"31","author":"S\u00fcsstrunk","year":"2021","journal-title":"Obes Surg"},{"key":"10.1016\/j.surg.2024.07.061_bib8","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00464-017-5794-4","article-title":"The natural history of perforated marginal ulcers after gastric bypass surgery","volume":"32","author":"Altieri","year":"2018","journal-title":"Surg Endosc"},{"key":"10.1016\/j.surg.2024.07.061_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.soard.2013.10.002","article-title":"Management and treatment outcomes of marginal ulcers after Roux-en-Y gastric bypass at a single high volume bariatric center","volume":"10","author":"Moon","year":"2014","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.surg.2024.07.061_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.soard.2008.10.011","article-title":"Revisional operations for marginal ulcer after Roux-en-Y gastric bypass","volume":"5","author":"Patel","year":"2009","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.surg.2024.07.061_bib11","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1007\/s00464-018-06618-5","article-title":"Marginal ulcer continues to be a major source of morbidity over time following gastric bypass","volume":"33","author":"Pyke","year":"2019","journal-title":"Surg Endosc"},{"key":"10.1016\/j.surg.2024.07.061_bib12","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1007\/s11695-020-04960-z","article-title":"Which factors correlate with marginal ulcer after surgery for obesity?","volume":"30","author":"Rodrigo","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/j.surg.2024.07.061_bib13","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s11605-023-05619-7","article-title":"Predictors of marginal ulcer after gastric bypass: a systematic review and meta-analysis","volume":"27","author":"Beran","year":"2023","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.surg.2024.07.061_bib14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/SLA.0000000000001300","article-title":"Risk factors for marginal ulcer after gastric bypass surgery for obesity: a population-based cohort study","volume":"263","author":"Sverd\u00e9n","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2024.07.061_bib15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-0030-1256951","article-title":"Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes","volume":"43","author":"Azagury","year":"2011","journal-title":"Endoscopy"},{"key":"10.1016\/j.surg.2024.07.061_bib16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/oby.21759","article-title":"H. Pylori as a predictor of marginal ulceration: a nationwide analysis","volume":"25","author":"Schulman","year":"2017","journal-title":"Obesity"},{"key":"10.1016\/j.surg.2024.07.061_bib17","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s00464-020-07650-0","article-title":"Marginal ulceration following Roux-en-Y gastric bypass: risk factors for ulcer development, recurrence and need for revisional surgery","volume":"35","author":"Di Palma","year":"2021","journal-title":"Surg Endosc"},{"key":"10.1016\/j.surg.2024.07.061_bib18","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1111\/j.1572-0241.2006.00770.x","article-title":"Predictors of endoscopic findings after Roux-en-Y gastric bypass","volume":"101","author":"Wilson","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.surg.2024.07.061_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.soard.2019.11.022","article-title":"Marginal ulcers after laparoscopic Roux-en-Y gastric bypass: analysis of the amount of daily and lifetime smoking on postoperative risk","volume":"16","author":"Dittrich","year":"2020","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.surg.2024.07.061_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11695-021-05850-8","article-title":"Why size matters: an evaluation of gastric pouch size in roux-en-Y gastric bypass using CT volumetric analysis and its effect on marginal ulceration","volume":"32","author":"Ayuso","year":"2022","journal-title":"Obes Surg"},{"key":"10.1016\/j.surg.2024.07.061_bib21","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.soard.2020.03.001","article-title":"Upper endoscopy after Roux-en-Y gastric bypass: diagnostic yield and factors associated with relevant findings","volume":"16","author":"Boerlage","year":"2020","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.surg.2024.07.061_bib22","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.soard.2022.03.019","article-title":"Nonsteroid anti-inflammatory drugs and the risk of peptic ulcers after gastric bypass and sleeve gastrectomy","volume":"18","author":"Skogar","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.surg.2024.07.061_bib23","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.surg.2024.07.061_bib24","author":"Peterson"},{"key":"10.1016\/j.surg.2024.07.061_bib25","first-page":"728","article-title":"Guidelines for prevention of NSAID-related ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.surg.2024.07.061_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/0003-4819-115-3-195","article-title":"Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial","volume":"115","author":"Agrawal","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.surg.2024.07.061_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000201171","article-title":"Does sucralfate prevent short-term NSAID induced damage to the gastroduodenal mucosa?","volume":"55","author":"Gudj\u00f3nsson","year":"1994","journal-title":"Digestion"},{"key":"10.1016\/j.surg.2024.07.061_bib28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/fampra\/cmx142","article-title":"Trends in prescribing of non-steroidal anti-inflammatory drugs in patients with cardiovascular disease: influence of national guidelines in UK primary care","volume":"35","author":"Chen","year":"2018","journal-title":"Fam Pract"},{"key":"10.1016\/j.surg.2024.07.061_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.13383","article-title":"Trends in use of prescription nonsteroidal anti-inflammatory medications before vs after implementation of a Florida law restricting opioid prescribing for acute pain","volume":"4","author":"Keshwani","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.surg.2024.07.061_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/phar.2488","article-title":"U.S. trends in prescription nonsteroidal anti-inflammatory drug use among patients with cardiovascular disease, 1988-2016","volume":"41","author":"Hwang","year":"2021","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.surg.2024.07.061_bib31","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1001\/jamainternmed.2018.4273","article-title":"Frequency and associations of prescription nonsteroidal anti-inflammatory drug use among patients with a musculoskeletal disorder and hypertension, heart failure, or chronic kidney disease","volume":"178","author":"Bouck","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.surg.2024.07.061_bib32","first-page":"1994","article-title":"Trends in prescribing of non-steroidal anti-inflammatory medications in the US ambulatory care setting from 2006 to 2016","volume":"24","author":"Keshwani","year":"2023","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.surg.2024.07.061_bib33","article-title":"A\u00a0scoping review of interventions to de-implement potentially harmful nonsteroidal anti-inflammatory drugs (NSAIDs) in healthcare settings","author":"Rockwell","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.surg.2024.07.061_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archinte.158.1.33","article-title":"Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs","volume":"158","author":"Garc\u00eda Rodr\u00edguez","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.surg.2024.07.061_bib35","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","article-title":"Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in\u00a0vitro analysis","volume":"96","author":"Warner","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.surg.2024.07.061_bib36","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/bmj.38232.680567.EB","article-title":"The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review","volume":"329","author":"Hooper","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.surg.2024.07.061_bib37","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11695-018-3526-z","article-title":"Multimodal postoperative pain control is effective and reduces opioid use after laparoscopic roux-en-Y gastric bypass","volume":"29","author":"Horsley","year":"2019","journal-title":"Obes Surg"},{"key":"10.1016\/j.surg.2024.07.061_bib38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.soard.2015.04.022","article-title":"The influence of prophylactic proton pump inhibitor treatment on the development of symptomatic marginal ulceration in Roux-en-Y gastric bypass patients: a historic cohort study","volume":"12","author":"Coblijn","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.surg.2024.07.061_bib39","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s11605-015-2765-8","article-title":"Is antisecretory therapy after pancreatoduodenectomy necessary? Meta-analysis and contemporary practices of pancreatic surgeons","volume":"19","author":"Butler","year":"2015","journal-title":"J\u00a0Gastrointest Surg"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606024006536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606024006536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:18:29Z","timestamp":1738203509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606024006536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":39,"alternative-id":["S0039606024006536"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2024.07.061","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonsteroidal anti-inflammatory drug (NSAID) prescribing after gastrojejunostomy: A preventable cause of morbidity","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2024.07.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108806"}}